News

San Antonio biotech acquires U.K. wound-care company

Acelity LP President and CEO Andrew Eckert says the company's acquisition of England's Crawford Healthcare ...

Kiromic founder says Houston biotech’s move to SA nearly a done deal

Houston-based immunotherapy company Kiromic is expected this month to approve moving its headquarters ...

Events

4th Annual SURF 2018

What: San Antonio Military Health System and Universities ResearchForum When: Thursday, June ...

SwRI 2018 International Human Performance Summit

June 30-July 1, 2018 The Summit will be hosted by Southwest Research Institute as part of its ongoing ...
News
June 8, 2018
Acelity LP President and CEO Andrew Eckert says the company's acquisition of England's Crawford Healthcare is a game-changer for the San Antonio-based biotech. CARLOS JAVIER SANCHEZ | SABJ By W. Scott ... More

June 5, 2018
Houston-based immunotherapy company Kiromic is expected this month to approve moving its headquarters to San Antonio. IMAGE PROVIDED BY GETTY IMAGES (DHORANDE) By W. Scott Bailey Senior Reporter, San ... More

June 1, 2018
By Bruce Selcraig, STAFF WRITER, San Antonio Express-News For the third time in 10 years, UT Health San Antonio has received a highly-competitive, $24 million National Institutes of Health grant to accelerate ... More

May 24, 2018
City Manager Sheryl Sculley said San Antonio officials have "worked diligently" on luring Houston-based biotech Kiromic Inc. CARLOS JAVIER SANCHEZ | SABJ By W. Scott Bailey, Senior Reporter, San ... More

May 21, 2018
Dr. Patrick Sung is headed back to UT Health San Antonio from Yale University. Photo Credit TERRY DAGRADI | YALE UNIVERSITY W. Scott Bailey, Senior Reporter, San Antonio Business Journal The Cancer ... More

May 21, 2018
The University of Texas at San Antonio's Bernard Arulanandam said the institution is moving closer to becoming eligible for funding from the National Research University Fund. GABE HERNANDEZ | SABJ By ... More

May 18, 2018
StemBioSys Inc. CEO Bob Hutchens says the San Antonio biotech is on track to significantly expand its product portfolio. CARLOS JAVIER SANCHEZ | SABJ By W. Scott Bailey–Senior Reporter, San Antonio ... More

May 9, 2018
Rapamycin Holdings Inc. expects it will soon get the clearance to conduct a first-in-human clinical trial for its novel drug at the UT Health San Antonio Mays Cancer Center. By W. Scott Bailey – ... More

April 12, 2018
David Spencer (left) and Dr. George Peoples speak about collaboration between the local entrepreneur community and the U.S. military at the InnoTech Conference.  JJ Velasquez / Rivard Report By JJ ... More

March 29, 2018
Ramon Coronado, who earned his doctoral degree from the University of Texas at San Antonio, said his early-stage company is writing a new playbook for stem cell research. COURTESY OF THE UNIVERSITY ... More

March 23, 2018
CytoBioscience CEO James Garvin says the company will remain rooted in San Antonio despite a new merger. The deal could position the Alamo City company for new acquisitions. Carlos Javier Sanchez | SABJ W. ... More

March 22, 2018
Fountainhead Investment Partners Managing Partner Brian Kieser said San Antonio could land a new biotech innovation campus. FILE PHOTO By W. Scott Bailey  – Senior Reporter, San Antonio Business ... More

March 19, 2018
BioBridge Global CEO Martin Landon is working to leverage strong revenue increases in 2017 into more impressive long-term gains. GABE HERNANDEZ | SABJ By W. Scott Bailey  – Senior Reporter, ... More

March 8, 2018
  Legacy Leader Dr. Francisco Cigarroa in San Antonio. GABE HERNANDEZ | SABJ By W. Scott Bailey, San Antonio Business Journal  Dr. Francisco Cigarroa's life experiences have helped shape ... More

March 1, 2018
BioAffinity Technologies CEO Maria Zannes said the San Antonio company will have more opportunity for collaboration and investment moving forward. CARLOS JAVIER SANCHEZ | SABJ San Antonio-based bioAffinity ... More

February 22, 2018
By David Holley, Xconomy San Antonio—A small Texas biotech that develops women’s health products, including a generic birth control ring, has received a $960,000 grant from the Department ... More

February 22, 2018
Ricardo Carrion, Jr., Ph.D. During the West African Ebola outbreak that began in 2013, an experimental biopharmaceutical drug called ZMappTM was a glimmer of hope in the midst of a health crisis. ... More

February 14, 2018
StemBioSys Inc. CEO Bob Hutchens said the company is making bold changes to gain bigger commercial audience for cell technologies. Carlos Javier Sanchez | SABJ W. Scott Bailey, Senior Reporter, San Antonio ... More

January 30, 2018
A temporary sign is installed highlighting the Mays Cancer Center name. SCOTT BALL / RIVARD REPORT BY Roseanna Garza, Rivard Report The UT Health San Antonio Cancer Center will be renamed the Mays Cancer ... More

January 22, 2018
Cris Daskevich is the new CEO for the Children's Hospital of San Antonio. Courtesy of CHRISTUS Health.  By W. Scott Bailey  –  Senior Reporter, San Antonio Business Journal Christus ... More

January 16, 2018
David Holley, Xconomy Texas — San Antonio—Evestra, a San Antonio life science company that develops women’s health products, has a new shareholder: pharmaceutical firm Gedeon Richter, ... More

January 13, 2018
By KIM JOHNSON Texas Public Radio The healthcare and bioscience sector is one of San Antonio's leading industries. In 2015, the industry had a $37 billion impact on the San Antonio economy and employed ... More

January 3, 2018
In this December 10, 2017 photo, Michael Cassidy, 26, tends his sleeping two-month-old son, Azrael Cassidy, after posing for a portrait in Houston.  Photo by Yi-Chin Lee/Houston Chronicle via AP By ... More

Stay informed. Subscribe to BioMed SA news alerts.